Cargando…

Immunoprevention approaches for cancer prevention

Detalles Bibliográficos
Autor principal:	Umar, Asad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081840/ http://dx.doi.org/10.1186/2051-1426-2-S1-P7

Ejemplares similares

An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
por: Gu, Kyle J., et al.
Publicado: (2020)

Cancer Immunoprevention and Public Health
por: Singh, Sandeep K., et al.
Publicado: (2017)

Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
por: Emran, Talha Bin, et al.
Publicado: (2022)

Modelling vaccination schedules for a cancer immunoprevention vaccine
por: Motta, Santo, et al.
Publicado: (2005)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

Vaccines for immunoprevention of DNA mismatch repair deficient cancers
por: Hernandez-Sanchez, Alejandro, et al.
Publicado: (2022)

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
por: Koyande, Navami Prabhakar, et al.
Publicado: (2022)

COVID-19: The Need for Immunoprevention at Industrial Scale
por: Halstead, Scott B.
Publicado: (2020)

Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
por: Centuori, Sara M., et al.
Publicado: (2021)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
por: Vogt, Annika, et al.
Publicado: (2004)

Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies
por: Bakir, Amira H., et al.
Publicado: (2015)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Hospital costs of immunopreventable diseases in the economically active population in Brazil
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician
por: Jackson, Katy, et al.
Publicado: (2022)

A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
por: Chen, Jie, et al.
Publicado: (2019)

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
por: Sei, Shizuko, et al.
Publicado: (2023)

Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer
por: Yuan, Bo, et al.
Publicado: (2022)

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
por: Tuohy, Vincent K., et al.
Publicado: (2016)

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023)

Toxoplasma Rhoptries: Unique Secretory Organelles and Source of Promising Vaccine Proteins for Immunoprevention of Toxoplasmosis
por: Dlugonska, Henryka
Publicado: (2008)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019)

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer
por: Annapragada, Ananth, et al.
Publicado: (2020)

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
por: Driggers, Lara, et al.
Publicado: (2009)

Different approaches for delivery of Intermittent Preventive Treatment (IPT) to pregnant women in Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2010)

Prostate cancer: histopathological analysis of 66 cases
por: Oluwole, Olabode Peter, et al.
Publicado: (2011)

Modulation of DNA damage prevention and signaling pathways in diet induced colon cancer prevention
por: Pedro, Dalila FN, et al.
Publicado: (2010)

Multimodal approach for surgical site infection prevention – results from a pilot site in Kenya
por: Ntumba, P, et al.
Publicado: (2015)

Urinary tract infection associated with indwelling catheters in a intensive care unit: a preventive approach
por: Silva, MR, et al.
Publicado: (2015)

Physical activity, BMI and cancer prevention in urban adults
por: Akarolo-Anthony, Sally N, et al.
Publicado: (2012)

P04-01 Slovenian approach to healthy and active aging - Fall prevention program for elderly living at home
por: Knific, Tjaša, et al.
Publicado: (2022)

Risk Management in students using the FMEA Method (Prospective Approach) to identify ‎risky cases in term of suicide and its prevention
por: Rezaei, Haniyeh, et al.
Publicado: (2019)

Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models
por: Wang, Jin, et al.
Publicado: (2021)

Delocalized lipophilic cations as a new therapeutic approach in cancer
por: Ribeiro, A Barbosa, et al.
Publicado: (2010)

Commissioning for infection prevention
por: Wright, D
Publicado: (2015)

A computational approach to identify transposable element insertions in cancer cells
por: Silva, Israel T, et al.
Publicado: (2011)

A probability of benefit (AUC) approach to phase II cancer trials
por: Silcocks, Paul
Publicado: (2015)

Development of a rapid screening approach for candidate gene sets in cancer
por: Wittig, R, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ndv4lj71i6piubvf3i2pb8sral